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Incubation of isolated hepatocytes with Ccl, results in early reduction of the intracellular calcium content, 
mostly due to loss from the mitochondrial compartment. Ccl, treatment directly affects mitochondrial func- 
tions as indicated by the inhibition of Ca*+ uptake in cells permeabilized to the ion by digitonin exposure 
and by the reduction of intracellular ATP content in hepatocytes incubated in a glucose-free medium. Such 
mitochondrial damage is not caused by CCl,-induced stimulation of lipid peroxidation since it is not pre- 
vented by cc-tocopherol, used at a concentration able to inhibit completely peroxidative reactions without 
interfering with Ccl, activation. All data together are in favour of a direct action of Ccl,-reactive metabo- 
lites on liver cell calcium homeostasis. 
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1. INTRODUCTION 
Perturbation of hepatocellular calcium homeo- 
stasis has been postulated to be one of the mecha- 
nisms responsible for causing cell death as a result 
of the exposure to a number of toxic compounds, 
including carbon tetrachloride [1,2]. In particular, 
one of the consequences of CC4 poisoning is the 
loss of Ca’+ -sequestering activity by the endo- 
plasmic reticulum [3]. This cellular change occurs 
as early as 5-10 min after haloalkane addition to 
liver microsomal fractions or isolated hepatocytes 
and requires CC4 activation by the cytochrome 
P450-dependent mixed-function oxidase system 
131. 
A recent study by Brattin and Waller [4] has 
shown that, despite impairment of the microsomal 
calcium pump, much of the decrease in intra- 
cellular Ca2+ in CCL-treated hepatocytes is due to 
loss from the mitochondrial compartment. 
Here, we have investigated in isolated rat hepa- 
tocytes the possible mechanisms responsible for 
+ To whom correspondence should be addressed 
the impairment of mitochondrial Ca2+ buffering 
activity. 
Mitochondria are, in fact, generally believed not 
to be involved in the CC4 activation process and 
thus probably not directly affected by free radical 
metabolites of CC4. On the other hand, they 
might be altered by some long-lived products of 
lipid peroxidation able to diffuse further in the cell 
environment. 
2. MATERIALS AND METHODS 
a-Tocopherol and CC4 were obtained from 
Merck, Darmstadt, cation ionophore A23 187 from 
Calbiochem Boehring, uncoupler protonophore 
CCCP (carbonyl cyanide m-chlorophenylhydra- 
zone) and metallochromic dye arsenazo III from 
Sigma. Collagenase (grade II) and ADP (sodium 
salt) were from Boehringer Biochemia, Mannheim. 
Percoll was obtained from Pharmacia, Uppsala. 
i4CC4 (spec. act. 26.9 mCi/mmol) was purchased 
from Amersham International, England. All other 
reagents were of the highest grade of purity 
available and were obtained from local suppliers. 
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Male Sprague-Dawley rats (200-250 g/body wt, 
fed ad libitum) were used. a-Tocopherol was in- 
jected intraperitoneally 15 h before killing at a 
dose of 100 mg/kg body wt dissolved in 1 vol. 
ethanol/9 vols 16% (v/v) Tween 80 in saline. 
Hepatocyte isolation and incubation conditions 
were essentially as described [5,6]. Isolated liver 
cell suspensions containing 3 x lo6 cells/ml were 
incubated in the presence of 10 ~1 CC4 placed in 
the centre well of 50-ml Erlenmeyer flasks to give 
a final concentration in the incubation medium of 
approx. 172 PM [S]. ADP-chelated Fe3+ was 
directly added to the hepatocyte suspension to give 
a final concentration of 2.5 mM ADP and 1OOpM 
Fe3+. 
Intracellular Ca2+ pools were measured by the 
arsenazo III assay, as described by Bellomo et al. 
[7] using a Hitachi-Perkin Elmer DB DW 557 spec- 
trophotometer operating at the wavelength pair 
654-685 nm. The system was calibrated by adding 
known amounts of CaClz at the end of each experi- 
ment, and the result expressed as nmol Ca2+/mg 
protein. Lipid peroxidation was measured in terms 
of malonaldehyde (MDA) production [5]. 
Intracellular ATP was measured spectrophoto- 
metrically in acid extracts by an enzymatic method 
using a Boehringer Biochemia kit. For covalent 
binding experiments i4CC4 was diluted with 
unlabelled CC4 to give a specific activity of 22.5 
,uCi/mmol and 10 ~1 placed in the central well of 
the incubation flask as mentioned above. Hepato- 
cyte proteins were processed as in [8] and radioac- 
tivity estimated with an LKB 1217 Rack Beta scin- 
tillation counter. 
3. RESULTS AND DISCUSSION 
Incubation of isolated hepatocytes in the pre- 
sence of CC4 leads to the reduction of about 70% 
of the total intracellular Ca2+ content; this loss is 
due to a lowering of both microsomal and mito- 
chondrial Ca2’ pools (fig.1). 
Reduction of microsomal Ca2+ content is consis- 
tent with the reported inhibition of Ca2+-seques- 
tering activity observed in both liver microsomes 
treated with CC4 and the endoplasmic reticulum 
fraction [3,4] isolated from hepatocytes previously 
intoxicated with the haloalkane. The loss of in- 
tracellular Ca 2+ however, is mostly due to the ,
reduction of the CCCP-releasable fraction, in- 
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Fig. 1. Alterations of intracellular Ca’+ compartmenta- 
tion following CC4 metabolism in isolated hepatocytes. 
(Left) Typical spectrophotometric traces illustrating the 
titration technique employed to measure intracellular 
Ca’+ pools. (a) Control hepatocytes after 30 min incuba- 
tion, (b) hepatocytes treated for 30 min with CC4. 
(Right) Time course of CCL-induced decrease in mito- 
chondrial Ca2+ content. Each point represents the mean 
of 5 different experiments. The absolute value of the 
CCCP-releasable Ca2+ pool was 1.05+0.15 nmol/mg 
protein. 
dicating that the mitochondrial Ca2+-sequestering 
activity is also affected. This alteration occurs as 
early as 15 min after CC4 addition and is not 
resolved on prolonging cell incubation up to 120 
min (fig.1). It is known that mitochondrial Ca2+ 
content is maintained through the concerted ac- 
tivity of distinct uptake and release routes (91. The 
ion uptake occurs via a uniport carrier, driven by 
the transmembrane potential generated during 
coupled respiration [lo]. The calcium release in- 
stead seems to involve exchange with Na+ and H+ 
[11,12]. We have investigated the mechanisms 
responsible for depletion of the mitochondrial 
Ca2+ pool in isolated hepatocytes preincubated for 
30 min with CC4 and then subsequently treated 
with a low concentration of digitonin to make the 
plasma membrane permeable to extracellular 
calcium. 
As illustrated in fig.2, the amount of Ca2+ se- 
questered by the mitochondria of CCL-poisoned 
cells is approx. 75% less than that taken up in con- 
trol hepatocytes. Thus CC4 not only induces the 
release of Ca2+ from mitochondria but also in- 
terferes with the uptake mechanisms, probably by 
affecting the processes which maintain the trans- 
membrane potential. Further evidence suggesting 
that CC4 directly damages mitochondria is given 
by the measurement of total ATP content of 
isolated hepatocytes incubated in a glucose-free 
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Fig.2. Alteration of mitochondrial Ca2+-sequestering ac- 
tivity by CC4 metabolism in isolated hepatocytes. Con- 
trol (a) or CCLintoxicated (b) hepatocytes were har- 
vested after 30 min incubation as described in section 2 
for determination of intracellular Ca2+ pools except hat 
the final incubation medium contained 20 ,uM CaC12. 
The absorbance changes due to Ca2+ sequestration by 
intracellular organelles were recorded upon addition of 
digitonin (12 pg/ml) to make permeable the plasma 
membrane; when Ca2+ uptake was complete, CCCP (10 
PM) then A23187 (15 FM) were added to titrate the in- 
tracellular pools. One experiment ypical of 2. 
medium, so as to reduce the cytosolic ATP resyn- 
thesis. 
Fig.3 shows that the ATP content of liver cells 
challenged with CC4 is reduced concomitantly 
with the decrease in mitochondrial calcium. 
Previous reports [13,14] have shown that CC4 
causes an increase in total mitochondrial Ca’+, as 
estimated by atomic absorption and radiolabelled 
isotope dilution, within several hours of rat intox- 
ication. However, as pointed out by Carafoli and 
Tiozzo [ 131, the calcium accumulated in the 
mitochondria is in a complexed not releasable 
form, and is thus not measurable by the present 
technique. Furthermore, calcium complexation 
might account for at least part of the decrease in 
FCCP-releasable Ca2+ in hepatocytes. Likewise, 
the above authors also observed impaired Ca2+ up- 
take and alterations of oxidative phosphorylation 
in the mitochondria obtained from CCL-treated 
rats [13]. 
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Fig.3. Decrease of intracellular ATP concentration by 
CC4 in isolated hepatocytes. Incubation conditions were 
essentially as described in section 2 except that glucose 
was omitted to minimise cytoplasmic resynthesis of 
ATP. At the times indicated samples were taken and 
processed for ATP enzymatic assay. (A) Untreated cells; 
(A) CCL-treated cells. One experiment ypical of 3. 
In isolated hepatocytes, as in whole liver, CC4 
is activated by the mixed-function oxidase system 
to a free radical intermediate responsible for either 
covalent binding to cell macromolecules or stimu- 
lation of lipid peroxidation [ 121. To investigate the 
possible involvement of peroxidative mechanisms 
in causing alterations of mitochondrial functions 
isolated hepatocytes have been prepared from cy- 
tocopherol-pretreated rats [ 151 and subsequently 
intoxicated with the haloalkane. As shown in table 
1 no detectable lipid peroxidation, measured MDA 
production, occurs in a-tocopherol-treated 
hepatocytes receiving CC4, while the haloalkane 
activation, indicated by the covalent binding of 
radioactive metabolites to cell protein, is not af- 
fected. When tested for mitochondrial calcium 
content and intracellular ATP concentration, LY- 
tocopherol-treated hepatocytes are not protected 
against the effect of CC4. 
Further indications that peroxidative reactions 
are not involved in causing mitochondrial damage 
derive from experiments where lipid peroxidation 
is induced in hepatocytes by ADP-iron. Under 
these conditions no decrease in mitochondrial 
Ca2+ content is observed (fig.4). In addition, when 
the plasma membranes of ADP-iron-treated cells 
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Table 1 
Effect of cu-tocopherol pretreatment on CC4 activation, stimulation of lipid peroxidation 
and derangement of mitochondrial functions in isolated hepatocytes 
Treatments Covalent binding MDA production CCCP-releasable Intracellular ATP 
(nmol CCLJmg (nmol/106 cells) Ca2+ (nmol/mg content 
protein) protein) (nmol/ lo6 cells) 
Cells from 
untreated rats 
Control - 0.40 f 0.08 1.05 13.47 f 0.82 
+ cc4 0.73 + 0.08 1.80 f 0.16 0.28 9.70 + 1.08 
Cells from LY- 
tocopherol-pre- 
treated rats 
Control 0.20 f 0.05 1.20 13.90 + 1.11 
+ cc4 0.80 + 0.09 0.33 f 0.04 0.31 10.72 f 0.96 
Isolated hepatocytes from untreated and cY-tocopherol pretreated rats were incubated for 
60 min at 37°C with or without CC4 as described in section 2. The values are means of 
2-4 experiments + SD 
are made permeable by digitonin, calcium uptake 
comparable to that of untreated cells occurs 
(fig.4). 
The possibility that some of the early effects or 
CC4 intoxication involve mitochondria was sug- 
gested by the some studies of Dianzani [16] and 
Artizzu et al. [17]. These authors observed mito- 
chondrial swelling in the liver of rats as early as 
cl Control ADP-Fez’ 
Fig.4. ADP-iron induced lipid peroxidation does not af- 
fect the ability of hepatocyte mitochondria to take up 
and retain Ca2+. Mitochondrial Ca2+ content (measured 
as CCCP-releasable Ca2+) and Ca2+ accumulated after 
digitonin treatment were measured in control and ADP- 
iron-treated (30 min) hepatocytes as described in section 
2. One experiment ypical of 2. 
30-60 min after CC4 intoxication in vivo. Also, 
uncoupling of oxidative phosphorylation and 
decrease in ATP content were observed in organelle 
preparations exposed in vitro to the same CC4 
concentration as found in the liver 30 min after ad- 
ministration of the haloalkane [17]. 
The present results indicate that the decrease in 
mitochondrial calcium uptake and ATP content 
occurs shortly after exposure of hepatocytes to 
CC4 and is not mediated by the stimulation of 
lipid peroxidation, appearing rather as a conse- 
quence of attack by free radical metabolites. Thus, 
2 possibilities exist, i.e. that free radicals might dif- 
fuse from their microsomal site of production to 
the mitochondria or alternatively that mitochon- 
dria themselves are able to activate CCL. Levy and 
Brabec [ 181 and De Castro et al. [ 191 have recently 
given some evidence in favour of this latter possi- 
bility. 
Concerning the significance of the impairment 
of calcium homeostasis as a mechanism of cell 
death in the case of CC4 poisoning, in contrast to 
what has been found with other toxic compounds 
[l], alterations in the intracellular Ca2+ distribu- 
tion do not result in an early loss of cell viability 
or in morphological alterations of the isolated 
hepatocytes [5]. This observation, however, does 
not exclude a possible later contribution of this 
cellular change to CCL-induced liver cell necrosis. 
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Such a consideration is based on the fact that in an 
almost identical experimental model in which CC4 
is substituted by iron, i.e. lipid peroxidation 
without the occurrence of haloalkylation, the even- 
tual hepatocyte damage is definitively lower [20]. 
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